UltraScan 650 Ultrasound Bone Densitometer Bone Sonometer for DXA DEXA BMD

Description

The CyberLogic UltraScan™ 650 is the first and only
FDA-approved
bone sonometer that measures bone mineral density (BMD), the most important factor in determining the risk of osteoporotic fracture. Conventional bone sonometers measure parameters like SOS and/or BUA. These parameters have poor correlation with BMD, usually less than 0.8, and thus these devices perform poorly in terms of identifying those individuals with osteoporosis and at increased risk of fracture. By contrast, the UltraScan™ 650 uses novel patented
net time delay (NTD) technology
which allows measurement of the quantity of bone, which in turn provides a direct evaluation of BMD; thus the UltraScan™ 650 is a true "ultrasound bone densitometer". Clinical studies on the UltraScan™ 650 show that its output, BMD
US
, is highly correlated (r = 0.93) with x-ray based (DXA) measures of BMD. BMD
DXA
has‒‒until now that is‒‒been the “gold standard” for bone assessment. Now, with the availability of the UltraScan™ 650, BMD can be measured without the need for DXA, without the ionizing radiation of x-rays, at lower cost and in less time (a 10-second test).
A brochure on the UltraScan 650 can be downloaded at "
Download Brochure
" and additional information on the UltraScan 650 can be found at "
More Information
". The UltraScan™ 650 is
the next generation bone densitometer
, and is an ideal tool for primary care offices (no state-licensed technician required to operate it), and is reimbursed under CPT code #76977. The UltraScan 650 can identify those individuals in need of therapeutic interventions, and its use will help in the prevention of debilitating osteoporotic fractures through timely therapeutic interventions.